SCHEMBL4209809

SCHEMBL4209809

[CH2]C(=O)c1cc2cccc(OC)c2o1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.75
RECQL P46063 1/20 0.75
KMT2A Q03164 2/20 0.73
ALDH1A1 P00352 2/20 0.73
RAB9A P51151 4/20 0.68
NPC1 O15118 3/20 0.68
SMN1; SMN2 Q16637 3/20 0.68
MEN1 O00255 1/20 0.68
MAPT P10636 3/20 0.64
HTT P42858 2/20 0.64
L3MBTL1 Q9Y468 1/20 0.57
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA3 P07451 1/20 0.57
CA4 P22748 1/20 0.57
CA6 P23280 1/20 0.57
CA5A P35218 1/20 0.57
CA7 P43166 1/20 0.57
CA9 Q16790 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978037 0.86 LMNA (0.77) LMNARECQLKMT2AALDH1A1RAB9A
SCHEMBL219813 0.86 LMNA (1.00) LMNARECQLKMT2AALDH1A1RAB9A
SCHEMBL3614366 0.84 LMNA (0.75) LMNARECQLKMT2AALDH1A1RAB9A
SCHEMBL4745478 0.84 KMT2A (1.00) LMNARECQLKMT2AALDH1A1RAB9A
SCHEMBL5584678 0.84 LMNA (0.75) LMNARECQLKMT2AALDH1A1RAB9A
SCHEMBL25062697 0.82 LMNA (0.71) LMNARECQLKMT2AALDH1A1RAB9A
SCHEMBL14259653 0.82 LMNA (0.71) LMNARECQLKMT2AALDH1A1RAB9A
SCHEMBL7055795 0.82 LMNA (0.71) LMNARECQLKMT2AALDH1A1RAB9A
SCHEMBL5723065 0.81 RAB9A (1.00) LMNARECQLKMT2AALDH1A1RAB9A
SCHEMBL219330 0.81 LMNA (0.69) LMNARECQLKMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785425-B2 11β-hydroxyandrosta-4-ene-3-ones SUN PHARMA ADVANCED RESEARCH COMPANY LTD. 2014-07-22 US disclosed
US-20090054388-A1 NOVEL 11 BETA-HYDROXYANDROSTA-4-ENE-3-ONES SUN PHARMA ADVANCE RESEARCH COMPANY (IN) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054388-A1 NOVEL 11 BETA-HYDROXYANDROSTA-4-ENE-3-ONES HSD11B1, HSD3B1, HSD3B2 LMNA 1076/4885RECQL 2511/4885KMT2A 4439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.